Your browser doesn't support javascript.
loading
Response to Letter Regarding Article, "Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial".
Shahbaznejad, Leila; Davoudi, Alireza; Eslami, Gohar; Markowitz, John S; Navaeifar, Mohammad Reza; Hosseinzadeh, Fatemeh; Movahedi, Faeze Sadat; Rezai, Mohammad Sadegh.
Afiliação
  • Shahbaznejad L; Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
  • Davoudi A; Antimicrobial Resistance Research Center, Department of Infectious Diseases, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
  • Eslami G; Department of Clinical Pharmacy, Faculty of Pharmacy, Cardiovascular Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
  • Markowitz JS; Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics and Precision Medicine, University of Florida, Gainesville, Florida.
  • Navaeifar MR; Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
  • Hosseinzadeh F; Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
  • Movahedi FS; Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
  • Rezai MS; Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran. Electronic address: drmsrezaii@yahoo.com.
Clin Ther ; 43(9): 1624-1626, 2021 09.
Article em En | MEDLINE | ID: mdl-34364698

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article